0
Skip to Content
BoulantLab
BoulantLab
Research
Team
Fun in the lab
Publications
Contact us
BoulantLab
BoulantLab
Research
Team
Fun in the lab
Publications
Contact us
Research
Team
Fun in the lab
Publications
Contact us

Our research on Pubmed

Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25

Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection

Read More
Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25

Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors

Read More
Mapping the epithelial-immune cell interactome upon infection in the gut and the upper airways
Steeve Boulant 3/31/25 Steeve Boulant 3/31/25

Mapping the epithelial-immune cell interactome upon infection in the gut and the upper airways

Read More
The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms
Steeve Boulant 6/19/19 Steeve Boulant 6/19/19

The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms

It all begins with an idea.

Read More
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters
Steeve Boulant 6/19/19 Steeve Boulant 6/19/19

The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters

It all begins with an idea.

Read More
Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells
Steeve Boulant 6/19/19 Steeve Boulant 6/19/19

Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells

It all begins with an idea.

Read More
A Model for Network-Based Identification and Pharmacological Targeting of Aberrant, Replication-Permissive Transcriptional Programs Induced by Viral Infection
Steeve Boulant 6/19/19 Steeve Boulant 6/19/19

A Model for Network-Based Identification and Pharmacological Targeting of Aberrant, Replication-Permissive Transcriptional Programs Induced by Viral Infection

It all begins with an idea.

Read More
Newer Posts